News
ABIO
3.460
+3.28%
0.110
Weekly Report: what happened at ABIO last week (0708-0712)?
Weekly Report · 11h ago
Citizens And 4 Other Stocks Under $5 Insiders Are Buying
When insiders purchase or sell shares, it indicates confidence or concern around the company's prospects. The Dow Jones index closed higher by more than 200 points on Friday. Recent notable insider transactions for penny stocks include ARCA biopharma, Douglas Elliman and Willamette Valley Vineyards.
Benzinga · 11h ago
Weekly Report: what happened at ABIO last week (0701-0705)?
Weekly Report · 07/08 12:01
Weekly Report: what happened at ABIO last week (0624-0628)?
Weekly Report · 07/01 12:02
Weekly Report: what happened at ABIO last week (0617-0621)?
Weekly Report · 06/24 12:12
Weekly Report: what happened at ABIO last week (0610-0614)?
Weekly Report · 06/17 12:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Calidi Biotherapeutics shares rose 29.7% to $0.25 during Monday's pre-market session. Entero Therapeutics (NASDAQ:ENTO) shares rose 22.41% during the session. Co-Diagnostics stock moved upwards by 14.07%. Sunshine Biopharma and Skye Bioscience were among the losers.
Benzinga · 06/10 12:06
Weekly Report: what happened at ABIO last week (0603-0607)?
Weekly Report · 06/10 12:03
Weekly Report: what happened at ABIO last week (0527-0531)?
Weekly Report · 06/03 12:07
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Bio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 70.4% to $3.51 during Monday's pre-market session. NewGenIvf Group and Structure Therapeutics among those moving upwards. Molecular Partners and ARCA biopharma also moved upwards.
Benzinga · 06/03 12:07
Weekly Report: what happened at ABIO last week (0520-0524)?
Weekly Report · 05/27 12:13
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SQSP, HIBB, ABIO, HMNF
Barchart · 05/23 11:28
Weekly Report: what happened at ABIO last week (0513-0517)?
Weekly Report · 05/20 12:03
12 Health Care Stocks Moving In Friday's Intraday Session
Akanda (NASDAQ:AKAN) shares increased by to $ during Friday's regular session. NovaBay Pharmaceuticals (NovaBay) and Doximity (Doximity) are among the gainers. Lucy Scientific Discovery (LSDI) and SINTX Techs (SINTX) lost ground.
Benzinga · 05/17 16:31
3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally
The cult of r/WallStreetBets is hyping up their favorite short-squeeze stocks. The meme stock rally for AMC Entertainment (AMC) is losing steam. The short squeeze stocks to watch are likely lesser-known companies with high short interest. Rent the Runway and Arca Biopharma are among the key companies to watch.
Investorplace · 05/14 17:48
GameStop Trader 'Roaring Kitty' Sparks Wall Street Rally In Heavily Shorted Stocks: What You Need To Know Right Now
Several stocks with high short interest rallied on Monday. The surge in meme stocks can be traced back to a social media post from Keith Gill. GameStop Corp (GME) shares surged on Monday after a surge in short interest. Gill is known as "Roaring Kitty" and "DeepF"
Benzinga · 05/13 20:38
Weekly Report: what happened at ABIO last week (0506-0510)?
Weekly Report · 05/13 12:21
ARCA BIOPHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
Former Attorney General of Louisiana Charles C. Foti, Jr. And the law firm of Kahn Swick & Foti are investigating the proposed merger of ARCA biopharma, Inc. And Oruka Therapeutics. KSF is seeking to determine whether the merger is fair to ARCA shareholders.
Barchart · 05/10 17:34
Weekly Report: what happened at ABIO last week (0429-0503)?
Weekly Report · 05/06 12:31
Weekly Report: what happened at ABIO last week (0422-0426)?
Weekly Report · 04/29 12:40
More
Webull provides a variety of real-time ABIO stock news. You can receive the latest news about Arca Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABIO
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. Gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that is developing for the treatment of atrial fibrillation in patients with heart failure. Its Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), is a protein therapeutic in clinical development as a potential treatment for patients with COVID-19. It is also evaluating options for development of its assets, including partnering and other strategic options.